Yang et al., 2022 - Google Patents
Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cellsYang et al., 2022
View HTML- Document ID
- 1297035908028113400
- Author
- Yang J
- Vamvini M
- Nigro P
- Ho L
- Galani K
- Alvarez M
- Tanigawa Y
- Renfro A
- Carbone N
- Laakso M
- Agudelo L
- Pajukanta P
- Hirshman M
- Middelbeek R
- Grove K
- Goodyear L
- Kellis M
- Publication year
- Publication venue
- Cell metabolism
External Links
Snippet
Exercise training is critical for the prevention and treatment of obesity, but its underlying mechanisms remain incompletely understood given the challenge of profiling heterogeneous effects across multiple tissues and cell types. Here, we address this …
- 210000001519 tissues 0 title abstract description 105
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cells | |
Ajaz et al. | Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 | |
Knudsen et al. | Interleukin-13 drives metabolic conditioning of muscle to endurance exercise | |
Van Der Spek et al. | Regulation of intracellular triiodothyronine is essential for optimal macrophage function | |
Rajbhandari et al. | IL-10 signaling remodels adipose chromatin architecture to limit thermogenesis and energy expenditure | |
Oral et al. | Inhibition of IKKɛ and TBK1 improves glucose control in a subset of patients with type 2 diabetes | |
Van der Kolk et al. | Subcutaneous adipose tissue and systemic inflammation are associated with peripheral but not hepatic insulin resistance in humans | |
de Gonzalo-Calvo et al. | Circulating inflammatory miRNA signature in response to different doses of aerobic exercise | |
Thompson et al. | Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial | |
Marcucci et al. | Context-dependent pharmacological effects of metformin on the immune system | |
Ahonen et al. | The association of adiponectin and low-grade inflammation with the course of metabolic syndrome | |
Tomalin et al. | Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis | |
Hepprich et al. | Postprandial hypoglycemia in patients after gastric bypass surgery is mediated by glucose-induced IL-1β | |
Tsilioni et al. | IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder | |
Baresic et al. | Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program | |
Nosacka et al. | Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle | |
Sheinboim et al. | An exercise-induced metabolic shield in distant organs blocks cancer progression and metastatic dissemination | |
Zhou et al. | Deciphering the decline of metabolic elasticity in aging and obesity | |
Gao et al. | Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation | |
Eyileten et al. | Altered circulating microRNA profiles after endurance training: a cohort study of ultramarathon runners | |
Lv et al. | Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis | |
Chen et al. | Overexpression of p53 accelerates puberty in high-fat diet–fed mice through Lin28/let-7 system | |
Blumhagen et al. | Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS | |
Fu et al. | Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy | |
Tang et al. | Diversity and heterogeneity in human breast cancer adipose tissue revealed at single-nucleus resolution |